Hospital
Trident Medical Center, LLC
Trident Medical Center, LLC was paid $4.12M by Medicaid between Jan 2018 and May 2020, across 206 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 16% of everything it billed.
33Billing provider infoTRIDENT MEDICAL CENTER, LLC
CHARLESTON, SC 29406
CHARLESTON, SC 29406
33aNPI1386721405assigned 11/01/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.12M
24GClaims293,213
24DCodes billed206
24AFirst – last monthJan 2018 – May 2020
Compared with peers
Next to other General Acute Care Hospital providers in South Carolina
Rank by total paid#55 of 115
Median peer was paid$2.47M
This provider vs. median1.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 132,396 | $1.88M | |
| 2019 | 132,798 | $1.91M | |
| 2020 | 28,019 | $322K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80053 | Comprehensive metabolic panel | 16% | 10,950 | 8,187 | $670K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 11% | 4,911 | 1,613 | $441K |
| 80048 | Basic metabolic panel (calcium, ionized) | 9.5% | 8,251 | 5,785 | $392K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 6.8% | 2,319 | 1,364 | $280K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 6.0% | 16,478 | 12,614 | $246K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3.8% | 3,776 | 3,100 | $157K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3.0% | 954 | 714 | $121K |
| 81001 | 2.7% | 12,014 | 9,322 | $110K | |
| 36415 | Collection of venous blood by venipuncture | 2.5% | 1,084 | 796 | $105K |
| 87081 | 2.5% | 2,035 | 1,753 | $104K | |
| 87275 | 2.5% | 3,197 | 2,667 | $104K | |
| 84702 | 2.3% | 1,659 | 1,256 | $96K |
194 more codes
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.0% | 2,603 | $82K |
| 99284 | Emergency room visit (serious) | 1.8% | 14,143 | $74K |
| 87210 | 1.4% | 796 | $58K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 1.3% | 347 | $55K |
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 4,288 | $55K |
| 82565 | 1.3% | 378 | $53K | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 1.3% | 35 | $52K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1.2% | 236 | $51K |
| 81002 | 1.2% | 350 | $50K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.2% | 3,092 | $48K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 3,570 | $45K |
| 87070 | 1.1% | 290 | $43K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 1,223 | $41K |
| 80047 | <1% | 631 | $41K | |
| 93971 | <1% | 669 | $37K | |
| 81025 | <1% | 5,704 | $36K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 2,757 | $25K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,770 | $22K |
| 73562 | <1% | 1,034 | $22K | |
| 73630 | <1% | 717 | $20K | |
| 76801 | <1% | 1,122 | $19K | |
| 72100 | <1% | 974 | $15K | |
| 85027 | <1% | 19,624 | $14K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 909 | $13K |
| 73610 | <1% | 490 | $13K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,098 | $13K |
| 73030 | <1% | 690 | $13K | |
| A9270 | Non-covered item or service | <1% | 13,933 | $12K |
| 73130 | <1% | 451 | $12K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 738 | $11K |
| 74019 | <1% | 277 | $10K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 952 | $10K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 930 | $10K |
| 87077 | <1% | 923 | $10K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 7,632 | $9K |
| 80076 | <1% | 615 | $9K | |
| 71045 | Radiologic examination, chest; single view | <1% | 5,579 | $9K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 484 | $9K |
| 72050 | <1% | 261 | $9K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 136 | $9K |
| 10060 | <1% | 71 | $9K | |
| 99285 | Emergency room visit (most serious) | <1% | 3,145 | $8K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 624 | $8K |
| 74018 | <1% | 238 | $8K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 88 | $7K |
| 73110 | <1% | 245 | $7K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,411 | $6K |
| 77336 | <1% | 253 | $6K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 790 | $6K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,946 | $6K |
| 85610 | <1% | 3,267 | $6K | |
| 84484 | <1% | 7,912 | $6K | |
| 86850 | <1% | 808 | $5K | |
| 81003 | <1% | 748 | $5K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 50 | $4K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 271 | $4K |
| 11045 | <1% | 730 | $4K | |
| 73502 | <1% | 254 | $3K | |
| 71250 | <1% | 22 | $3K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 9,834 | $3K |
| 72072 | <1% | 194 | $3K | |
| 84703 | <1% | 470 | $2K | |
| 83605 | <1% | 2,244 | $2K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,370 | $2K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 74 | $2K |
| 76642 | <1% | 143 | $2K | |
| 12011 | <1% | 15 | $2K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 139 | $1K |
| 84439 | <1% | 382 | $1K | |
| 93922 | <1% | 12 | $1K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 12 | $1K |
| 86900 | <1% | 1,431 | $1K | |
| 76830 | Ultrasound, transvaginal | <1% | 59 | $1K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 19 | $1K |
| 36600 | <1% | 15 | $1K | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 373 | $1K |
| 76770 | <1% | 31 | $999.18 | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 1,724 | $989.47 |
| 73080 | <1% | 56 | $953.92 | |
| 87420 | <1% | 120 | $895.87 | |
| 73590 | <1% | 48 | $891.64 | |
| 77066 | Tomosynthesis, mammo | <1% | 17 | $814.97 |
| 86592 | <1% | 110 | $746.20 | |
| 80061 | Lipid panel | <1% | 921 | $729.81 |
| 77065 | Tomosynthesis, mammo | <1% | 35 | $724.92 |
| 85651 | <1% | 271 | $716.37 | |
| 82607 | <1% | 48 | $672.04 | |
| 82247 | <1% | 49 | $631.53 | |
| 85379 | <1% | 880 | $548.09 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,266 | $499.10 |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 107 | $467.28 |
| 73140 | <1% | 17 | $387.86 | |
| 83880 | <1% | 2,492 | $331.49 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,446 | $227.19 |
| 87147 | <1% | 779 | $220.07 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 35 | $213.23 |
| 87040 | <1% | 1,399 | $213.09 | |
| 86701 | <1% | 40 | $193.48 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,582 | $185.77 |
| 86780 | <1% | 29 | $175.64 | |
| 36000 | <1% | 251 | $132.87 | |
| 82550 | <1% | 892 | $122.95 | |
| 87205 | <1% | 491 | $118.42 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 44 | $113.22 |
| 82728 | <1% | 14 | $107.16 | |
| 29125 | <1% | 13 | $90.92 | |
| 86141 | <1% | 137 | $79.54 | |
| 97597 | <1% | 60 | $39.27 | |
| 80164 | <1% | 165 | $29.44 | |
| 83735 | <1% | 2,635 | $5.24 | |
| 84132 | <1% | 108 | $4.16 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 1,286 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 6,019 | $0.00 |
| 87186 | 0% | 925 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 3,474 | $0.00 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 382 | $0.00 |
| 90714 | 0% | 368 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 4,230 | $0.00 |
| 84100 | 0% | 886 | $0.00 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | 0% | 1,805 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 1,066 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 0% | 468 | $0.00 |
| J1644 | Injection, heparin sodium, per 1000 units | 0% | 889 | $0.00 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | 0% | 86 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 750 | $0.00 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 0% | 196 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 310 | $0.00 |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 0% | 28 | $0.00 |
| 85046 | 0% | 29 | $0.00 | |
| 93017 | 0% | 271 | $0.00 | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 0% | 108 | $0.00 |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 0% | 28 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 136 | $0.00 |
| 93970 | 0% | 14 | $0.00 | |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 57 | $0.00 |
| 82310 | 0% | 17 | $0.00 | |
| A6212 | Foam dressing, wound cover, sterile, pad size 16 sq. in. or less, with any size adhesive border, each dressing | 0% | 75 | $0.00 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 17 | $0.00 |
| 86703 | 0% | 124 | $0.00 | |
| 82248 | 0% | 29 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 0% | 18 | $0.00 |
| 78815 | Positron emission tomography (PET) for limited area imaging | 0% | 35 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 65 | $0.00 |
| 85007 | 0% | 17 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 1,097 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 775 | $0.00 |
| 85730 | 0% | 2,672 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 0% | 1,992 | $0.00 |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 3,294 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 5,085 | $0.00 |
| 96376 | 0% | 392 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 1,888 | $0.00 |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 0% | 232 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 571 | $0.00 |
| G0378 | Hospital observation service, per hour | 0% | 1,631 | $0.00 |
| 83690 | 0% | 4,245 | $0.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 289 | $0.00 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 1,655 | $0.00 |
| 82553 | 0% | 403 | $0.00 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 0% | 1,037 | $0.00 |
| 87276 | 0% | 3,195 | $0.00 | |
| 82330 | 0% | 319 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 696 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 3,041 | $0.00 |
| 88342 | 0% | 17 | $0.00 | |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 0% | 521 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 96 | $0.00 |
| J1815 | Injection, insulin, per 5 units | 0% | 1,157 | $0.00 |
| 86901 | 0% | 1,431 | $0.00 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 168 | $0.00 |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 0% | 63 | $0.00 |
| 82150 | 0% | 14 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 488 | $0.00 |
| J0500 | Injection, dicyclomine hcl, up to 20 mg | 0% | 44 | $0.00 |
| 97162 | 0% | 72 | $0.00 | |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 105 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 80 | $0.00 |
| 86762 | 0% | 38 | $0.00 | |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 472 | $0.00 |
| C1769 | Guide wire | 0% | 324 | $0.00 |
| 87340 | 0% | 40 | $0.00 | |
| 70496 | 0% | 27 | $0.00 | |
| 86140 | 0% | 15 | $0.00 | |
| J3490 | Unclassified drugs | 0% | 73 | $0.00 |
| 70486 | 0% | 26 | $0.00 | |
| 70498 | 0% | 16 | $0.00 | |
| 82803 | 0% | 16 | $0.00 | |
| 74022 | 0% | 15 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 13 | $0.00 |
| 86920 | 0% | 19 | $0.00 | |
| 85018 | 0% | 35 | $0.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 23 | $0.00 |
| 73090 | 0% | 22 | $0.00 | |
| J7999 | Compounded drug, not otherwise classified | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMILLER, ANDY (CFO)
| Provider | Location | Paid |
|---|---|---|
| Trident Medical Center, LLC | Charleston, SC | $166K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.